{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:52:37Z","timestamp":1792047157707,"version":"4.4.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671616"],"award-info":[{"award-number":["81671616"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871278"],"award-info":[{"award-number":["81871278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004610","name":"Science and technology Project of Jiangsu Province","doi-asserted-by":"crossref","award":["BE2018671"],"award-info":[{"award-number":["BE2018671"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00198-020-05360-w","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T11:02:30Z","timestamp":1586862150000},"page":"1401-1409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Effects of glucocorticoids on osteoporosis in rheumatoid arthritis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"31","author":[{"given":"Y.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-1621","authenticated-orcid":false,"given":"L.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"issue":"4","key":"5360_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/bor.0000000000000608","volume":"31","author":"G Adami","year":"2019","unstructured":"Adami G, Saag KG (2019) Glucocorticoid-induced osteoporosis update. Curr Opin Rheumatol 31(4):388\u2013393. https:\/\/doi.org\/10.1097\/bor.0000000000000608","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"5360_CR2","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/acr.20295","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 62(11):1515\u20131526. https:\/\/doi.org\/10.1002\/acr.20295","journal-title":"Arthritis Care Res"},{"issue":"4","key":"5360_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/rheumatology\/key169","volume":"58","author":"Y Palmowski","year":"2019","unstructured":"Palmowski Y, Buttgereit T, Buttgereit F (2019) The 70th anniversary of glucocorticoids in rheumatic diseases: the second youth of an old friend. Rheumatology (Oxford, England) 58(4):580\u2013587. https:\/\/doi.org\/10.1093\/rheumatology\/key169","journal-title":"Rheumatology (Oxford, England)"},{"issue":"10","key":"5360_CR4","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/rheumatology\/keu135","volume":"53","author":"A Kavanaugh","year":"2014","unstructured":"Kavanaugh A, Wells AF (2014) Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis. Rheumatology (Oxford, England) 53(10):1742\u20131751. https:\/\/doi.org\/10.1093\/rheumatology\/keu135","journal-title":"Rheumatology (Oxford, England)"},{"issue":"6","key":"5360_CR5","first-page":"727","volume":"18","author":"GA Wells","year":"2010","unstructured":"Wells GA, Shea BJ, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P (2010) The Newcastle\u2013Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric 18(6):727\u2013734","journal-title":"Appl Eng Agric"},{"issue":"7414","key":"5360_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327(7414):557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"Bmj"},{"issue":"4","key":"5360_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264\u2013269, w264. https:\/\/doi.org\/10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"issue":"8","key":"5360_CR8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/art.1780310805","volume":"31","author":"PN Sambrook","year":"1988","unstructured":"Sambrook PN, Eisman JA, Champion GD, Pocock NA (1988) Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 31(8):973\u2013978. https:\/\/doi.org\/10.1002\/art.1780310805","journal-title":"Arthritis Rheum"},{"issue":"10","key":"5360_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/ard.54.10.801","volume":"54","author":"NFA Peel","year":"1995","unstructured":"Peel NFA, Moore DJ, Barrington NA, Bax DE, Eastell R (1995) Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 54(10):801\u2013806","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5360_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s10067-002-8274-7","volume":"21","author":"K Shibuya","year":"2002","unstructured":"Shibuya K, Hagino H, Morio Y, Teshima R (2002) Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol 21(2):150\u2013158. https:\/\/doi.org\/10.1007\/s10067-002-8274-7","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5360_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11657-017-0329-0","volume":"12","author":"CC Ma","year":"2017","unstructured":"Ma CC, Xu SQ, Gong X, Wu Y, Qi S, Liu W, Xu JH (2017) Prevalence and risk factors associated with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis. Arch Osteoporos 12(1):33. https:\/\/doi.org\/10.1007\/s11657-017-0329-0","journal-title":"Arch Osteoporos"},{"issue":"2","key":"5360_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00198-011-1584-3","volume":"23","author":"M Ghazi","year":"2012","unstructured":"Ghazi M, Kolta S, Briot K, Fechtenbaum J, Paternotte S, Roux C (2012) Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int 23(2):581\u2013587. https:\/\/doi.org\/10.1007\/s00198-011-1584-3","journal-title":"Osteoporos Int"},{"issue":"12","key":"5360_CR13","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/rheumatology\/40.12.1375","volume":"40","author":"RN de Nijs","year":"2001","unstructured":"de Nijs RN, Jacobs JW, Bijlsma JW, Lems WF, Laan RF, Houben HH, ter Borg EJ, Huisman AM, Bruyn GA, van Oijen PL, Westgeest AA, Algra A, Hofman DM (2001) Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis. Rheumatology (Oxford, England) 40(12):1375\u20131383. https:\/\/doi.org\/10.1093\/rheumatology\/40.12.1375","journal-title":"Rheumatology (Oxford, England)"},{"issue":"2","key":"5360_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00774-005-0657-9","volume":"24","author":"K Arai","year":"2006","unstructured":"Arai K, Hanyu T, Sugitani H, Murai T, Fujisawa J, Nakazono K, Kondo N, Endo N (2006) Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. J Bone Miner Metab 24(2):118\u2013124. https:\/\/doi.org\/10.1007\/s00774-005-0657-9","journal-title":"J Bone Miner Metab"},{"issue":"10","key":"5360_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s10067-011-1762-x","volume":"30","author":"HH Dao","year":"2011","unstructured":"Dao HH, Do QT, Sakamoto J (2011) Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis. Clin Rheumatol 30(10):1353\u20131361. https:\/\/doi.org\/10.1007\/s10067-011-1762-x","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5360_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00198-010-1201-x","volume":"22","author":"L Caplan","year":"2011","unstructured":"Caplan L, Hines AE, Williams E, Prochazka AV, Saag KG, Cunningham F, Hutt E (2011) An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis. Osteoporos Int 22(1):305\u2013315. https:\/\/doi.org\/10.1007\/s00198-010-1201-x","journal-title":"Osteoporos Int"},{"issue":"4","key":"5360_CR17","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3904\/kjim.2014.29.4.509","volume":"29","author":"JH Lee","year":"2014","unstructured":"Lee JH, Cho SK, Han M, Kim D, Bae SC, Sung YK (2014) Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis? Korean J Intern Med 29(4):509\u2013515. https:\/\/doi.org\/10.3904\/kjim.2014.29.4.509","journal-title":"Korean J Intern Med"},{"key":"5360_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12891-015-0733-9","volume":"16","author":"ML Rentero","year":"2015","unstructured":"Rentero ML, Amigo E, Chozas N, Fernandez Prada M, Silva-Fernandez L, Abad Hernandez MA, Rodriguez Barrera JM, del Pino-Montes J (2015) Prevalence of fractures in women with rheumatoid arthritis and\/or systemic lupus erythematosus on chronic glucocorticoid therapy. BMC Musculoskelet Disord 16:300. https:\/\/doi.org\/10.1186\/s12891-015-0733-9","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"5360_CR19","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1007\/s00198-016-3646-z","volume":"27","author":"A Balasubramanian","year":"2016","unstructured":"Balasubramanian A, Wade SW, Adler RA, Lin CJF, Maricic M, O'Malley CD, Saag K, Curtis JR (2016) Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int 27(11):3239\u20133249. https:\/\/doi.org\/10.1007\/s00198-016-3646-z","journal-title":"Osteoporos Int"},{"issue":"2","key":"5360_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10067-017-3943-8","volume":"37","author":"DL Conn","year":"2018","unstructured":"Conn DL, Tiliakos A, Bao G, Liu S, Li S, Easley KA (2018) Effect of daily low dose prednisone, divided or single daily dose, in the treatment of African Americans with early rheumatoid arthritis. Clin Rheumatol 37(2):355\u2013365. https:\/\/doi.org\/10.1007\/s10067-017-3943-8","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5360_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4081\/reumatismo.2017.922","volume":"69","author":"M Rossini","year":"2017","unstructured":"Rossini M, Viapiana O, Vitiello M, Malavolta N, La Montagna G, Maddali Bongi S, Di Munno O, Nuti R, Manzini CU, Ferri C, Bogliolo L, Mathieu A, Cantatore F, Del Puente A, Muratore M, Grassi W, Frediani B, Saviola G, Delvino P, Mirone L, Ferraccioli G, Tripi G, Piazza I, Gatti D (2017) Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the glucocorticoid induced OsTeoporosis TOol (GIOTTO) study. Reumatismo 69(1):30\u201339. https:\/\/doi.org\/10.4081\/reumatismo.2017.922","journal-title":"Reumatismo"},{"key":"5360_CR22","doi-asserted-by":"publisher","unstructured":"Malochet-Guinamand S, Lambert C, Gossec L, Soubrier M, Dougados M (2019) Evaluation of the implementation of guidelines on the treatment of osteoporosis in patients with rheumatoid arthritis. J Rheumatol. https:\/\/doi.org\/10.3899\/jrheum.180889","DOI":"10.3899\/jrheum.180889"},{"issue":"7","key":"5360_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11926-019-0836-7","volume":"21","author":"G Adami","year":"2019","unstructured":"Adami G, Saag KG (2019) Osteoporosis pathophysiology, epidemiology, and screening in rheumatoid arthritis. Curr Rheumatol Rep 21(7):34. https:\/\/doi.org\/10.1007\/s11926-019-0836-7","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"5360_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.bbrc.2016.07.036","volume":"477","author":"G Shen","year":"2016","unstructured":"Shen G, Ren H, Qiu T, Liang WQ, Tang J, Zhang Z, Yao Z, Zhao W, Jiang X (2016) Effect of glucocorticoid withdrawal on glucocorticoid inducing bone impairment. Biochem Biophys Res Commun 477(4):1059\u20131064. https:\/\/doi.org\/10.1016\/j.bbrc.2016.07.036","journal-title":"Biochem Biophys Res Commun"},{"key":"5360_CR25","doi-asserted-by":"publisher","unstructured":"Aeberli D, Fankhauser N, Zebaze R, Bonel H, Moller B, Villiger PM (2019) Effect of rheumatoid arthritis and age on metacarpal bone shaft geometry and density: a longitudinal pQCT study in postmenopausal women. Semin Arthritis Rheum. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.08.003","DOI":"10.1016\/j.semarthrit.2019.08.003"},{"issue":"7","key":"5360_CR26","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00198-015-3089-y","volume":"26","author":"M Monadi","year":"2015","unstructured":"Monadi M, Javadian Y, Cheraghi M, Heidari B, Amiri M (2015) Impact of treatment with inhaled corticosteroids on bone mineral density of patients with asthma: related with age. Osteoporos Int 26(7):2013\u20132018. https:\/\/doi.org\/10.1007\/s00198-015-3089-y","journal-title":"Osteoporos Int"},{"issue":"3","key":"5360_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ogc.2011.07.001","volume":"38","author":"JC Lo","year":"2011","unstructured":"Lo JC, Burnett-Bowie SA, Finkelstein JS (2011) Bone and the perimenopause. Obstet Gynecol Clin N Am 38(3):503\u2013517. https:\/\/doi.org\/10.1016\/j.ogc.2011.07.001","journal-title":"Obstet Gynecol Clin N Am"},{"key":"5360_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4471-0759-0_10","volume-title":"Bone densitometry in the elderly","author":"T Masud","year":"2000","unstructured":"Masud T, Miller PD (2000) Bone densitometry in the elderly. Springer, London"},{"issue":"11","key":"5360_CR29","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1007\/s00198-006-0202-2","volume":"17","author":"EM Lewiecki","year":"2006","unstructured":"Lewiecki EM, Binkley N, Bilezikian JP, Kendler DL, Leib ES, Petak SM (2006) Official positions of the International Society for Clinical Densitometry. Osteoporos Int 17(11):1700\u20131701. https:\/\/doi.org\/10.1007\/s00198-006-0202-2","journal-title":"Osteoporos Int"},{"issue":"8","key":"5360_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1177\/0961203319855122","volume":"28","author":"EL Lai","year":"2019","unstructured":"Lai EL, Huang WN, Chen HH, Hsu CY, Chen DY, Hsieh TY, Hung WT, Lin CT, Lai KL, Tang KT, Chen YM, Chen YH (2019) Ten-year fracture risk by FRAX and osteoporotic fractures in patients with systemic autoimmune diseases. Lupus 28(8):945\u2013953. https:\/\/doi.org\/10.1177\/0961203319855122","journal-title":"Lupus"},{"issue":"12","key":"5360_CR31","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1136\/annrheumdis-2015-208958","volume":"75","author":"C Klop","year":"2016","unstructured":"Klop C, de Vries F, Bijlsma JW, Leufkens HG, Welsing PM (2016) Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density. Ann Rheum Dis 75(12):2095\u20132100. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208958","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5360_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jocd.2018.10.007","volume":"22","author":"KD Elde","year":"2019","unstructured":"Elde KD, Madsen OR (2019) FRAX 10-yr fracture risk in rheumatoid arthritis-assessments with and without bone mineral density may lead to very different results in the individual patient. J Clin Densitom 22(1):31\u201338. https:\/\/doi.org\/10.1016\/j.jocd.2018.10.007","journal-title":"J Clin Densitom"},{"issue":"3","key":"5360_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jbspin.2010.02.009","volume":"77","author":"A Ruyssen-Witrand","year":"2010","unstructured":"Ruyssen-Witrand A, Fautrel B, Saraux A, Le-Loet X, Pham T (2010) Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Joint Bone Spine 77(3):246\u2013251. https:\/\/doi.org\/10.1016\/j.jbspin.2010.02.009","journal-title":"Joint Bone Spine"},{"issue":"10","key":"5360_CR34","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"TP van Staa","year":"2006","unstructured":"van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C (2006) Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54(10):3104\u20133112. https:\/\/doi.org\/10.1002\/art.22117","journal-title":"Arthritis Rheum"},{"issue":"10","key":"5360_CR35","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/jbmr.3523","volume":"33","author":"A Balasubramanian","year":"2018","unstructured":"Balasubramanian A, Wade SW, Adler RA, Saag K, Pannacciulli N, Curtis JR (2018) Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions. J Bone Miner Res 33(10):1881\u20131888. https:\/\/doi.org\/10.1002\/jbmr.3523","journal-title":"J Bone Miner Res"},{"issue":"6","key":"5360_CR36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15(6):993\u20131000. https:\/\/doi.org\/10.1359\/jbmr.2000.15.6.993","journal-title":"J Bone Miner Res"},{"issue":"5","key":"5360_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/s-0042-101896","volume":"141","author":"M Krasselt","year":"2016","unstructured":"Krasselt M, Baerwald C (2016) An update on glucocorticoid-induced osteoporosis. Dtsch Med Wochenschr (1946) 141(5):352\u2013357. https:\/\/doi.org\/10.1055\/s-0042-101896","journal-title":"Dtsch Med Wochenschr (1946)"},{"issue":"6","key":"5360_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s2213-8587(18)30075-5","volume":"6","author":"KG Saag","year":"2018","unstructured":"Saag KG, Wagman RB, Geusens P, Adachi JD, Messina OD, Emkey R, Chapurlat R, Wang A, Pannacciulli N, Lems WF (2018) Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study. Lancet Diabetes Endocrinol 6(6):445\u2013454. https:\/\/doi.org\/10.1016\/s2213-8587(18)30075-5","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"5360_CR39","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/acr.23279","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, Humphrey MB, Lane NE, Magrey M, Miller M, Morrison L, Rao M, Byun Robinson A, Saha S, Wolver S, Bannuru RR, Vaysbrot E, Osani M, Turgunbaev M, Miller AS, McAlindon T (2017) 2017 American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 69(8):1095\u20131110. https:\/\/doi.org\/10.1002\/acr.23279","journal-title":"Arthritis Care Res"},{"issue":"9","key":"5360_CR40","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","volume":"23","author":"S Lekamwasam","year":"2012","unstructured":"Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgstrom F, Cooper C, Diez Perez A, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23(9):2257\u20132276. https:\/\/doi.org\/10.1007\/s00198-012-1958-1","journal-title":"Osteoporos Int"},{"issue":"12","key":"5360_CR41","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s40266-019-00714-4","volume":"36","author":"HG Raterman","year":"2019","unstructured":"Raterman HG, Lems WF (2019) Pharmacological management of osteoporosis in rheumatoid arthritis patients: a review of the literature and practical guide. Drugs Aging 36(12):1061\u20131072. https:\/\/doi.org\/10.1007\/s40266-019-00714-4","journal-title":"Drugs Aging"},{"issue":"11","key":"5360_CR42","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1359\/jbmr.070716","volume":"22","author":"P Lips","year":"2007","unstructured":"Lips P (2007) Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res 22(11):1668\u20131671. https:\/\/doi.org\/10.1359\/jbmr.070716","journal-title":"J Bone Miner Res"},{"issue":"9588","key":"5360_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/s0140-6736(07)61342-7","volume":"370","author":"BM Tang","year":"2007","unstructured":"Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370(9588):657\u2013666. https:\/\/doi.org\/10.1016\/s0140-6736(07)61342-7","journal-title":"Lancet"},{"issue":"10","key":"5360_CR44","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381. https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"issue":"3","key":"5360_CR45","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00774-018-0955-7","volume":"37","author":"N Iwamoto","year":"2019","unstructured":"Iwamoto N, Okamoto M, Tsuji S, Endo Y, Takatani A, Shimizu T, Umeda M, Fukui S, Sumiyoshi R, Igawa T, Koga T, Kawashiri SY, Aramaki T, Ichinose K, Tamai M, Nakamura H, Origuchi T, Eguchi K, Ueki Y, Kawakami A (2019) Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs. J Bone Miner Metab 37(3):554\u2013562. https:\/\/doi.org\/10.1007\/s00774-018-0955-7","journal-title":"J Bone Miner Metab"},{"issue":"10117","key":"5360_CR46","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/s0140-6736(17)32137-2","volume":"391","author":"DL Kendler","year":"2018","unstructured":"Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Moricke R, Lopez-Romero P (2018) Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet 391(10117):230\u2013240. https:\/\/doi.org\/10.1016\/s0140-6736(17)32137-2","journal-title":"Lancet"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05360-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-020-05360-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-020-05360-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T19:24:21Z","timestamp":1618341861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-020-05360-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["5360"],"URL":"https:\/\/doi.org\/10.1007\/s00198-020-05360-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}